Braidwell »

Pacific Biosciences of California shares owned by Braidwell

Quarter-by-quarter ownership of Pacific Biosciences of California (PACB) shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in Pacific Biosciences of California

Tip: Access up to 7 years of quarterly data

All positions including Pacific Biosciences of California held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pacific Biosciences of California by Braidwell

Quarter filed Position value Share count Share price at filing
2023-03-31 $13M 1.1M 11.58

More positions owned by Braidwell

Guardant Health Debt 1.250% 2/1 (Principal)
Caris Life Sciences (CAI)
Novocure Note 11/0 (Principal)
Xenon Pharmaceuticals (XENE)
Cg Oncology (CGON)
Neurocrine Biosciences (NBIX)
Repligen Corp Note 1.000%12/1 (Principal)
Krystal Biotech (KRYS)
Nuvalent Inc-a (NUVL)
Neogenomics Note 0.250% 1/1 (Principal)
Soleno Therapeutics (SLNO)
Irhythm Technologies Note 1.500% 9/0 (Principal)
Edgewise Therapeutics (EWTX)
Ironwood Pharmaceuticals Note 1.500% 6/1 (Principal)
Inspire Med Sys (INSP)

View all positions for Braidwell

Top funds holding Pacific Biosciences of California

ARK Investment Management
BlackRock
Softbank Group Corp
Vanguard Group
Edmond De Rothschild Holding
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Geode Capital Management
State Street Corporation
Madrone Advisors
Millennium Management
Point72
Koss-Olinger Consulting
Citadel Advisors
Amiral Gestion

View all funds holding Pacific Biosciences of California